Effects of adrenergic blocking agents on lipid mobilization from canine subcutaneous adipose tissue after sympathetic nerve stimulation.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D004285:Dogs; D004558:Electric Stimulation; D004878:Ergotamine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005990:Glycerol / Q000097:blood; D050356:Lipid Metabolism; D009578:Nitrobenzenes / Q000494:pharmacology; D010477:Perfusion; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000502:physiology*; D013565:Sympatholytics / Q000494:pharmacology*
D000605:Amino Alcohols; D004983:Ethanolamines; D005230:Fatty Acids, Nonesterified; D009578:Nitrobenzenes; D013565:Sympatholytics; D011433:Propranolol; D005990:Glycerol; D004878:Ergotamine; D010646:Phentolamine